Application 021428

Type
NDA
Sponsor
TAKEDA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREVACIDLANSOPRAZOLETABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL15MGYesNo
002PREVACIDLANSOPRAZOLETABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL30MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-106Prevacid SoluTablansoprazoleRebel Distributors CorpNDACurrent
55154-0253PrevacidlansoprazoleCardinal HealthNDACurrent
55154-0253PrevacidlansoprazoleCardinal Health 107, LLCNDACurrent
55154-0253PrevacidlansoprazoleCardinal HealthNDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-543Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent
64764-544Prevacid SoluTablansoprazoleTakeda Pharmaceuticals America, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77890SUPPL 2023-08-10
77891SUPPL 2023-08-09
70479SUPPL2022-03-10
70464SUPPL2022-03-10
70410SUPPL2022-03-07
65415SUPPL2020-11-30
65414SUPPL2020-11-30
65376SUPPL2020-11-30
64587SUPPL2020-09-17
64568SUPPL2020-09-14
54573SUPPL2018-06-14
54572SUPPL2018-06-14
54518SUPPL2018-06-11
54517SUPPL2018-06-11
54516SUPPL2018-06-11
53708SUPPL2018-04-17
53695SUPPL2018-04-16
50184SUPPL2017-10-25
50101SUPPL2017-10-19
45713SUPPL2016-10-31
45663SUPPL2016-10-26
27750SUPPL2015-12-18
36899SUPPL2015-12-17
36900SUPPL2014-12-29
27751SUPPL2014-12-24
5349SUPPL2012-10-02
36898SUPPL2012-10-01
5350SUPPL2012-05-09
15447SUPPL2012-05-07
23659ORIG2011-12-20
15446SUPPL2011-11-01
27749SUPPL2011-10-31
36896SUPPL2011-06-07
5347SUPPL2011-06-03
36897SUPPL2011-05-26
5348SUPPL2011-05-25
15445SUPPL2010-09-10
36895SUPPL2010-05-17
5346SUPPL2010-05-17
27748SUPPL2009-11-12
15444SUPPL2009-08-13
15443SUPPL2008-11-07
27747SUPPL2008-10-29
21650SUPPL2008-07-31
5345SUPPL2008-04-23
5344SUPPL2007-07-05
15442SUPPL2007-06-27
36894SUPPL2006-04-13
5343SUPPL2006-04-13
42153ORIG2005-06-23
36893SUPPL2004-12-21
27746SUPPL2004-06-23
5342SUPPL2003-08-15
27745ORIG2002-08-30
15441ORIG2002-08-30